A Policy Model of Human Immunodeficiency Virus Screening and Intervention

The epidemics of acquired immunodeficiency syndrome AIDS and its causative agent, the human immunodeficiency virus HIV, are serious and growing. In response to the epidemic, policy makers have instituted a variety of interventions, often before careful studies of program costs and benefits have been carried out. We have developed an analytic decision model to assess HIV screening and intervention policies. The model is a dynamic compartmental epidemic model that captures disease transmission and disease progression, behavioral changes, and the effects of screening and other interventions. We illustrate the model by analyzing screening programs aimed at reducing the birthrate of HIV-infected infants.

[1]  I. Wilkerson Prenuptial AIDS screening a strain in Illinois. , 1988, The New York times on the Web.

[2]  D. Berns,et al.  HIV seroprevalence in newborns in New York State. , 1989, JAMA.

[3]  M. Gail,et al.  Disease prevention models of voluntary confidential screening for human immunodeficiency virus (HIV). , 1989, Statistics in medicine.

[4]  S. Friedman,et al.  HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. , 1988, Reviews of infectious diseases.

[5]  R. Anderson,et al.  Epidemiology of HIV infection and AIDS: incubation and infectious periods, survival and vertical transmission. , 1988, AIDS.

[6]  J. Hegarty,et al.  The medical care cost of human immunodeficiency virus-infected children in Harlem. , 1988, JAMA.

[7]  N. Ling The Mathematical Theory of Infectious Diseases and its applications , 1978 .

[8]  R. Sherer AIDS: Principles, Practices, and Politics , 1988 .

[9]  R. Redfield,et al.  Measurement of the false positive rate in a screening program for human immunodeficiency virus infections. , 1988, The New England journal of medicine.

[10]  C. Revelle,et al.  A mathematical model for determining case finding and treatment activities in tuberculosis control programs. , 1970, The American review of respiratory disease.

[11]  Hau L. Lee,et al.  Mass Screening Models for Contagious Diseases with No Latent Period , 1988, Oper. Res..

[12]  Edward H. Kaplan,et al.  What are the Risks of Risky Sex? Modeling the AIDS Epidemic , 1989, Oper. Res..

[13]  S. Levin Lectu re Notes in Biomathematics , 1983 .

[14]  C. Griscelli,et al.  A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. , 1989 .

[15]  E H Kaplan,et al.  Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. , 1989, Reviews of infectious diseases.

[16]  B. Kinosian,et al.  Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system. , 1990, JAMA.

[17]  P. Selwyn,et al.  Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. , 1989, JAMA.

[18]  E. H. Kaplan,et al.  So What If the Program Ain't Perfect? , 1989 .

[19]  MOTHER-TO-CHILD TRANSMISSION OF HIV INFECTION , 1988 .

[20]  J. Yorke,et al.  Gonorrhea Transmission Dynamics and Control , 1984 .

[21]  J. Ward,et al.  Statistical analysis of the stages of HIV infection using a Markov model. , 1989, Statistics in medicine.

[22]  L. Gostin Public health strategies for confronting AIDS. Legislative and regulatory policy in the United States. , 1989, JAMA.

[23]  E. Belongia,et al.  Border hopping as a consequence of premarital HIV screening: the Kenosha diamond. , 1988, JAMA.